Vitality, perceived social support and disease activity determine the performance of social roles in recently diagnosed multiple sclerosis: A longitudinal analysis

Journal of Rehabilitation Medicine

Volumn 40, Issue 2, 2008, Pages 151-157

  de Groot, Vincent ^a   Beckerman, Heleen ^a   Twisk, Jos W ^a   Uitdehaag, Bernard M ^a   Hintzen, Rogier Q ^b   Minneboo, Arjan ^a   Lankhorst, Gustaaf J ^a   Polman, Chris H ^a   Bouter, Lex M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Disability evaluation; Fatigue; Multiple sclerosis; Prognosis; Social support

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SHORT FORM 36; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; SOCIAL STATUS; SOCIAL SUPPORT;

ADOLESCENT; ADULT; COHORT STUDIES; DISABILITY EVALUATION; FATIGUE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; SOCIAL ADJUSTMENT; SOCIAL SUPPORT;

EID: 40949130496     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0145     Document Type: Article

References (44)

1. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993; 116: 117-134.
2. Weinshenker BG, Rice GPA, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991; 114: 1045-1056.
3. Amato MP, Ponziani G. A prospective study on the prognosis of multiple sclerosis. Neurol Sci 2000; 21: S831-S838.
4. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126: 770-782.
5. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
6. WHO. International Classification of Functioning, Disability and Health: ICF. Geneva: WHO; 2001.
7. Geuskens GA, Burdorf A, Hazes JM. Consequences of rheumatoid arthritis for performance of social roles - a literature review. J Rheumatol 2007; 34: 1248-1260.
8. Anderson RT, Aaronson NK, Wilkin D. Critical review of the international assessments of health- related quality of life. Quality of Life Research 1993; 2: 369-395.
9. Romney DM, Evans DR. Toward a general model of health-related quality of life. Quality of Life Research 1996; 5: 235-241.
10. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al. Translation, validation, and forming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 1055-1068.
11. Cieza A, Stucki G. Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Qual Life Res 2005; 14: 1225-1237.
12. Murphy N, Confavreux C, Haas J, Konig N, Roullet E, Sailer M, et al. Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. J Neurol Neurosurg Psychiatry 1998; 65: 460-466.
13. Paltamaa J, Sarasoja T, Wikstrom J, Malkia E. Physical functioning in multiple sclerosis: a population-based study in central Finland. J Rehabil Med 2006; 38: 339-345.
14. Rothwell PM. Quality of life in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 65: 433.
15. Hemmett L, Holmes J, Barnes M, Russell N. What drives quality of life in multiple sclerosis? QJM 2004; 97: 671-676.
16. Brunet DG, Hopman WM, Singer MA, Edgar CM, MacKenzie TA. Measurement of health-related quality of life in multiple sclerosis patients. Can J Neurol Sci 1996; 23: 99-103.
17. Somerset M, Peters TJ, Sharp DJ, Campbell R. Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis. Qual Life Res 2003; 12: 21-29.
18. de Groot V, Beckerman H, Lankhorst GJ, Polman CH, Bouter LM. The initial course of daily functioning in multiple sclerosis: a three-year follow-up study. Mult Scler 2005; 11: 713-718.
19. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
20. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Amer Geriatrics Soc 1968; 16: 622-626.
21. Kalkers NF, Bergers L, de Groot V, Lazeron RH, van Walderveen MA, Uitdehaag BM, et al. Concurrent validity of the MS Functional Composite using MRI as a biological disease marker. Neurology 2001; 56: 215-219.
22. Bot JC, Barkhof F, Polman CH, Nijeholt GJ, de Groot V, Bergers E, et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 2004; 62: 226-233.
23. Wallston KA, Wallston BS, DeVellis R. Development of the multidimensional health locus of control scales. Health Educ Monogr 1978; 6: 160-170.
24. Sanderman R, Arrindell WA, Ranchor AV, Eysenck HJ, Eysenck SBG. Eysenck Personality Questionnaire (EPQ). Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken Rijksuniversiteit Groningen, 1997.
25. Van Sonderen E. Sociale Steun Lijst - Interakties (SSL-I) en Sociale Steun Lijst - Discrepanties (SSL-D). Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken Rijksuniversiteit Groningen; 1997.
26. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-691.
27. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-1123.
28. Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res 1981; 4: 483-492.
29. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122: 871-882.
30. Rossier P, Wade DT. Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment. Arch Phys Med Rehabil 2001; 82: 9-13.
31. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130.
32. Twisk JW. Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol 2004; 19: 769-776.
33. Steyerberg EW, Eijkemans MJ, Habbema JD. Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol 1999; 52: 935-942.
34. Twisk JW, editor. Applied longitudinal data analysis for epidemiology: a practical guide. 1 edn. Cambridge: Cambridge University Press; 2003.
35. Rice GP, Incorvaia B, Munari L, Ebers G, Polman C, D'Amico R, et al. Interferon in relapsing-remitting multiple sclerosis. Cochrane Database Syst Rev 2001; CD002002.
36. Filippini G, Munari L, Incorvaia B, Ebers GC, Polman C, D'Amico R, et al. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 2003; 361: 545-552.
37. Krupp LB, Christodoulou C. Fatigue in multiple sclerosis. Curr Neurol Neurosci Rep 2001; 1: 294-298.
38. Lazeron RH, Boringa JB, Schouten M, Uitdehaag BM, Bergers E, Lindeboom J, et al. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Mult Scler 2005; 11: 524-531.
39. Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P. Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult Scler 2005; 11: 592-601.
40. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996; 39: 432-441.
41. Hogan BE, Linden W, Najarian B. Social support interventions - do they work? Clin Psychol Rev 2002; 22: 381-440.
42. Freeman JA, Langdon DW, Hobart JC, Thompson AJ. The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol 1997; 42: 236-244.
43. Patti F, Ciancio MR, Reggio E, Lopes R, Palermo F, Cacopardo M, et al. The impact of outpatient rehabilitation on quality of life in multiple sclerosis. J Neurol 2002; 249: 1027-1033.
44. Pozzilli C, Brunetti M, Amicosante AM, Gasperini C, Ristori G, Palmisano L, et al. Home based management in multiple sclerosis: results of a randomised controlled trial. J Neurol Neurosurg Psychiatry 2002; 73: 250-255.